BrightGene Bio-Medical Technology Co., Ltd. (SHA:688166)
China · Delayed Price · Currency is CNY 35.81
+1.45 (4.22%)
At close: Sep 30, 2026
SHA:688166 Market Cap
SHA:688166 has a market cap or net worth of 15.59 billion as of October 2, 2026. Its market cap has decreased by -37.92% in one year.
Market Cap
15.59B
Enterprise Value
17.22B
Revenue
1.36B
Ranking
n/a
PE Ratio
154.42
Stock Price
35.81
ChartMarket Cap Chart
Since November 8, 2019, SHA:688166's market cap has increased from 12.55B to 15.59B, an increase of 24.19%. That is a compound annual growth rate of 3.19%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 30, 2026 | 15.59B | -24.85% |
| Dec 31, 2025 | 20.74B | 62.70% |
| Dec 31, 2024 | 12.75B | -13.79% |
| Dec 29, 2023 | 14.79B | 55.07% |
| Dec 30, 2022 | 9.54B | -36.65% |
| Dec 31, 2021 | 15.05B | -19.85% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Nov 8, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Sino Biological,Inc. | 19.34B |
| Yili Chuanning Biotechnology | 18.28B |
| HitGen | 17.91B |
| Sinocelltech Group | 17.43B |
| GemPharmatech | 15.52B |
| Anhui Anke Biotechnology (Group) | 14.35B |
| Shanghai Medicilon | 14.16B |
| Nanjing Vazyme Biotech | 14.08B |